Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Inflammation
Published in: Inflammation 3/2001

01-06-2001

Dysregulated Cytokine Production in Human Cystic Fibrosis Bronchial Epithelial Cells

Authors: Arlene A. Stecenko, Gayle King, Keizo Torii, Richard M. Breyer, Ryszard Dworski, Timothy S. Blackwell, John W. Christman, Kenneth L. Brigham

Published in: Inflammation | Issue 3/2001

Login to get access
Metadata
Title
Dysregulated Cytokine Production in Human Cystic Fibrosis Bronchial Epithelial Cells
Authors
Arlene A. Stecenko
Gayle King
Keizo Torii
Richard M. Breyer
Ryszard Dworski
Timothy S. Blackwell
John W. Christman
Kenneth L. Brigham
Publication date
01-06-2001
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Inflammation / Issue 3/2001
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1023/A:1011080229374

Other articles of this Issue 3/2001

Inflammation 3/2001 Go to the issue

OriginalPaper

Poly ADP Ribose-Polymerase Inhibitors Prevent the Upregulation of ICAM-1 and E-selectin in Response to Th1 Cytokine Stimulation

OriginalPaper

Adrenomedullin Suppresses fMLP-Induced Upregulation of CD11b of Human Neutrophils

OriginalPaper

Effects of Heat Pretreatment on Histopathology, Cytokine Production, and Surfactant in Endotoxin-Induced Acute Lung Injury

OriginalPaper

Inhibition of the Adherence of T-Lymphocytes to Epithelial Cells by a Cyclic Peptide Derived from Inserted Domain of Lymphocyte Function-Associated Antigen-1

OriginalPaper

Species Dependence for Binding of Small Molecule Agonist and Antagonists to the C5a Receptor on Polymorphonuclear Leukocytes

OriginalPaper

Homocysteine Augments Cytokine-Induced Chemokine Expression in Human Vascular Smooth Muscle Cells: Implications for Atherogenesis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits